Veltassa (Patiromer)
patiromer 16.8 g powder for oral liquid, 30 sachets · ORAL · PBS code 13620W
AUTHORITY_REQUIREDWhat it costs
AU$325.89 PBS-determined price per 30 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2023-09-01.
- • Repeats: 5.
- • PBS program: GE.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Chronic hyperkalaemia
Initial PBS-subsidised treatment (including grandfathered patients)
Patient must have stage 3 to stage 4 chronic kidney disease; AND
The condition must be inadequately controlled by a low potassium diet.; AND
Patient must have experienced at least 2 episodes of hyperkalaemia (defined as serum potassium levels of at least 6.0 mmol/L) within the 12 months prior to commencing this drug; AND
The treatment must not be in place of emergency treatment of hyperkalaemia; AND
Patient must be undergoing treatment with a renin angiotensin aldosterone system inhibitor; or
Patient must be indicated for treatment with a renin angiotensin aldosterone system inhibitor, but unable to tolerate this due to prior occurrence of hyperkalaemia; AND
Must be treated by a specialist medical practitioner with experience in the diagnosis and management of chronic kidney disease.
Sponsor: Seqirus (Australia) Pty Ltd ABN 66 120 398 067
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.